National Center for Advancing Translational Sciences; Notice of Closed Meetings, 3971 [2015-01225]
Download as PDF
Federal Register / Vol. 80, No. 16 / Monday, January 26, 2015 / Notices
emcdonald on DSK67QTVN1PROD with NOTICES
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Fogarty International
Center Advisory Board.
Date: February 10, 2015.
Closed: February 10, 2015, 8:00 a.m. to
1:30 p.m.
Agenda: Review of grant applications.
Place: National Institutes of Health,
Lawton L. Chiles International House,
Bethesda, MD 20892.
Open: February 10, 2015 1:45 p.m. to 5:00
p.m.
Agenda: Update and discussion of current
and planned FIC activities.
Place: National Institutes of Health,
Lawton L. Chiles International House,
Bethesda, MD 20892.
Contact Person: Kristen Weymouth,
Fogarty International Center, National
Institutes Of Health, 31 Center Drive, Room
B2c02, Bethesda, MD 20892, (301) 496–1415,
WEYMOUTHK@MAIL.NIH.GOV.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: www.nih.gov/
fic/about/advisory.html, where an agenda
and any additional information for the
meeting will be posted when available.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.106, Minority International
Research Training Grant in the Biomedical
and Behavioral Sciences; 93.154, Special
International Postdoctoral Research Program
in Acquired Immunodeficiency Syndrome;
VerDate Sep<11>2014
18:48 Jan 23, 2015
Jkt 235001
93.168, International Cooperative
Biodiversity Groups Program; 93.934, Fogarty
International Research Collaboration Award;
93.989, Senior International Fellowship
Awards Program, National Institutes of
Health HHS)
Dated: January 16, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–01228 Filed 1–23–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel, R13 Conference Grant
Review.
Date: February 26, 2015.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892.
Contact Person: Sailaja Koduri, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, 6701 Democracy
Blvd., Room 1074, Bethesda, MD 20892, 301–
435–0813, Sailaja.koduri@nih.gov.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel, New Therapeutic Uses
(NTU) 1—Neurosciences.
Date: March 4–5, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Sheri A. Hild, Ph.D.,
Scientific Review Officer, Office of Grants
Management and Scientific Review, National
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
3971
Center for Advancing Translational Sciences
(NCATS), National Institutes of Health, 6701
Democracy Blvd., Democracy 1, Room 1082,
Bethesda, MD 20892–4874, 301–435–0811,
hildsa@mail.nih.gov.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel, New Therapeutic Uses
(NTU) 2.
Date: March 11–12, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Sheri A. Hild, Ph.D.,
Scientific Review Officer, Office of Grants
Management and Scientific Review, National
Center for Advancing Translational Sciences
(NCATS), National Institutes of Health, 6701
Democracy Blvd., Democracy 1, Room 1082,
Bethesda, MD 20892–4874, 301–435–0811,
hildsa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: January 20, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–01225 Filed 1–23–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, ‘‘Human Immunology
Project Consortium (U19)’’.
Date: February 18–20, 2015.
Time: 8:00 a.m. to 5:00 p.m.
E:\FR\FM\26JAN1.SGM
26JAN1
Agencies
[Federal Register Volume 80, Number 16 (Monday, January 26, 2015)]
[Notices]
[Page 3971]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01225]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel, R13 Conference Grant Review.
Date: February 26, 2015.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892.
Contact Person: Sailaja Koduri, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Center for Advancing
Translational Sciences, 6701 Democracy Blvd., Room 1074, Bethesda,
MD 20892, 301-435-0813, Sailaja.koduri@nih.gov.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel, New Therapeutic Uses (NTU) 1--
Neurosciences.
Date: March 4-5, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sheri A. Hild, Ph.D., Scientific Review Officer,
Office of Grants Management and Scientific Review, National Center
for Advancing Translational Sciences (NCATS), National Institutes of
Health, 6701 Democracy Blvd., Democracy 1, Room 1082, Bethesda, MD
20892-4874, 301-435-0811, hildsa@mail.nih.gov.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel, New Therapeutic Uses (NTU) 2.
Date: March 11-12, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sheri A. Hild, Ph.D., Scientific Review Officer,
Office of Grants Management and Scientific Review, National Center
for Advancing Translational Sciences (NCATS), National Institutes of
Health, 6701 Democracy Blvd., Democracy 1, Room 1082, Bethesda, MD
20892-4874, 301-435-0811, hildsa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: January 20, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-01225 Filed 1-23-15; 8:45 am]
BILLING CODE 4140-01-P